WHO: Recognition for Swissmedic and two other authorities
On 30 October 2023, the World Health Organization (WHO) recognized regulatory authorities as "WHO-Listed Authorities" for the first time. WHO-Listed Authorities (WLA) are regulatory authorities that operate in accordance with international standards and fulfil the requirements based on an established benchmarking and performance evaluation process.
The three authorities to receive this status are the Swiss Agency for Therapeutic Products Swissmedic, the Health Sciences Authority HSA, Singapore, and the Ministry of Food and Drug Safety MFDS, Republic of Korea. This means that Swissmedic, the HSA and the MFDS are considered trustworthy regulatory authorities whose decisions can be used by other bodies as a basis for their own decisions.
With the WLA list, the WHO aims to ensure that only safe, effective, and high-quality medical products are on the market worldwide.
The members of the Technical Advisory Group for WHO-Listed Authorities (TAG-WLA) met for the first time on 11 and 12 September 2023 at WHO headquarters in Geneva and unanimously recommended the listing of Swissmedic, HSA and MFDS.
Source:
WHO: Statement
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
